Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2001
11/01/2001CA2405543A1 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
11/01/2001CA2402123A1 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
11/01/2001CA2399741A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
11/01/2001CA2372673A1 Cyclic amidine compounds
10/2001
10/31/2001EP1149580A1 Use of heteroaryl substituted N-(Indole-2-Carbonyl-) amides for the manufacture of a medicament for the treatment of infection
10/31/2001EP1149094A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149089A2 Process to prepare cyclic-sulfur fluorine containing oxazolidinones
10/31/2001EP1149087A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
10/31/2001EP1149083A1 Morpholinobenzamide salts
10/31/2001EP1066281B1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods
10/31/2001EP0876356B1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001EP0737192B1 Substituted morpholine derivatives and their use as therapeutic agents
10/31/2001CN1320121A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320119A Sulfonyltriazol derivatives and their use for combating micro-organisms
10/31/2001CN1320118A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320037A Antiviral indoleoxoacetyl piperazine derivatives
10/30/2001US6310211 8-hydroxy-7-substituted quinolines as anti-viral agents
10/30/2001US6310079 Non-steroidal antiinflammatory agents
10/30/2001US6310069 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
10/30/2001US6310058 Antimycobacterial agents
10/30/2001CA2113189C Diaminic compounds, preparation, use and intermediates
10/30/2001CA2074723C Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
10/30/2001CA2048027C 3-arylindole and 3-arylindazole derivatives
10/25/2001WO2001079262A1 Pyrazinone and pyridinone derivatives as thrombin inhibitors
10/25/2001WO2001079261A1 Tetrahydro-azepinone derivatives as thrombin inhibitors
10/25/2001WO2001079246A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/25/2001WO2001079202A1 Processes for the preparation of thiazolidinedione derivatives and intermediates
10/25/2001WO2001079197A1 ACTIVATORS FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ (PPARδ)
10/25/2001WO2001079195A2 Pyridine and pyrazine derivatives as thrombin inhibitors
10/25/2001WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001WO2001079167A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/25/2001WO2001078719A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078654A2 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001US20010034445 Compounds such as 3-(3,4-Dihydro-8-((((6-amino2-pyridinyl) methyl)methylamino)carbonyl)-1-methyl-2,5-dioxo-1h-1,4-benzo diazepine)4-propanoic acid used as antiinflammatories, anticarcinogenics, and to treat angiogenesis, restenosis, etc
10/25/2001US20010034352 Cardiovascular disorders
10/25/2001US20010034351 A quinazoline compound
10/25/2001DE10020899A1 New 9-oxa-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease
10/25/2001DE10020517A1 New 13-halo or cyano-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease
10/25/2001CA2406475A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/25/2001CA2405696A1 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001CA2405597A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001CA2404639A1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/25/2001CA2402374A1 Processes for the preparation of thiazolidinedione derivatives and intermediates
10/24/2001EP1147105A1 Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatement of vascular diseases
10/24/2001EP1147104A1 Aromatic heterocyclic compounds as antiinflammatory agents
10/24/2001EP1147096A1 Herbicidal oxadiazolidines
10/24/2001EP1147094A1 Non-peptide glp-1 agonists
10/24/2001EP1147093A1 Substituted bicyclic derivatives useful as anticancer agents
10/24/2001EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/24/2001EP0856002B1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
10/24/2001EP0835246B1 Aromatic compounds and pharmaceutical compositions containing them
10/24/2001EP0648212B1 Benzoxazole and benzothiazole derivatives as pharmaceutical
10/24/2001CN1319100A Isoquinoline derivatives with angiogenesis inhibiting activity
10/24/2001CN1319097A Benzoxazine and benzothiazine derivatives and their use in medicines
10/24/2001CN1319096A Quinazoline derivatives and pharmaceutical applications thereof
10/24/2001CN1319094A Imidazolyl derivatives
10/24/2001CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001CN1319012A Method for treating diabetes employing ap2 inhibitor and combination
10/24/2001CN1073565C New 3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, processes for their preparation
10/23/2001US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
10/23/2001US6306873 Substituted β-thiocarboxylic acids
10/23/2001US6306864 Cerebral deficits subsequent to or resulting from cardiac bypass surgery and grafting, stroke, cerebral ischemia, spinal cord trauma, head trauma
10/23/2001US6306860 2,5-pyridinedicarboxylic acid derivatives
10/23/2001US6306852 Indole derivatives useful as endothelin receptor antagonists
10/23/2001US6306850 Chlorocyclopropyl-3-(2-chlorophenyl)-2-hydroxypropyl)2,4-dihyd ro-(1,2,4)-triazole-3-thione as fungicides
10/23/2001US6306840 Cell adhesion inhibitors
10/23/2001CA2083179C Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
10/23/2001CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
10/18/2001WO2001077107A1 Oxazole derivatives and their uses as tyrosine kinase inhibitors
10/18/2001WO2001077104A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
10/18/2001WO2001077101A1 Chemical compounds
10/18/2001WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists
10/18/2001WO2001077092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/18/2001WO2001077089A1 New neurokinin antagonists for use as medicaments
10/18/2001WO2001077080A2 Pyrazole compounds having anti proliferative activity
10/18/2001WO2001077078A1 Novel pyridones and their use as modulators of serine hydrolase enzymes
10/18/2001WO2001076629A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001WO2001038316A3 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands
10/18/2001US20010031781 Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors
10/18/2001US20010031777 Heterocyclic compounds and their therapeutic use
10/18/2001US20010031772 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals
10/18/2001US20010031759 Novel heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
10/18/2001DE10016893A1 Substituierte Phenyluracile Substituted Phenyluracils
10/18/2001CA2405163A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001CA2405089A1 Benzoamide piperidine containing compounds and related compounds
10/18/2001CA2404760A1 Oxazole derivatives and their uses as tyrosine kinase inhibitors
10/18/2001CA2403012A1 Chemical compounds
10/18/2001CA2372352A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/17/2001EP1144408A1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application
10/17/2001EP1144407A1 Cyclic guanidine derivatives and their use as pesticides
10/17/2001EP1144405A1 Triazole compounds with dopamine-d3-receptor affinity
10/17/2001EP1144404A1 Piperidinylquinolines as protein tyrosine kinase inhibitors
10/17/2001EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors
10/17/2001EP1144402A2 Substituted oximes and hydrazones as neurokinin antagonists
10/17/2001EP1144395A1 2-amino-benzoxazinone derivatives for the treatment of obesity
10/17/2001EP1144393A2 Heterocyclic derivatives and their use as integrin inhibitor
1 ... 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 ... 647